IBRUTINIB IN RELAPSE OR REFRACTORY PRIMARY CNS AND VITREO‐RETINAL LYMPHOMA. RESULTS OF THE PRIMARY END‐POINT OF THE ILOC PHASE II STUDY FROM THE LYSA AND THE FRENCH LOC NETWORK

Saved in:
Bibliographic Details
Published in:Hematological oncology 2017-06, Vol.35 (S2), p.72-72
Main Authors: Soussain, C., Choquet, S., Houillier, C., Bijou, F., Houot, R., Boyle, E., Gressin, R., Nicolas‐Virelizier, E., Barrie, M., Moluçon‐Chabrot, C., Lelez, M., Clavert, A., Coisy, S., Bretonnière, M. Ertault, El Yamani, A., Touitou, V., Cassoux, N., Boussetta, S., Broussais, F., Gelas‐Dore, B., Barzic, N., Ghesquières, H., Hoang‐Xuan, K.
Format: Article
Language:English
Subjects:
Central nervous system
Lymphoma
Retina
Targeted cancer therapy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.2437_59